Aug 2026· Die Innere Medizin· Vol 67, pp. 1063 - 1072· 0 citations· 20 references
Medicine
TL;DR
A practice-oriented evaluation of the indications, clinical benefits, and safety of modern diabetes technologies and suggests that technologies should be offered according to individual needs, abilities, preferences, and life circumstances and implemented early, including at the time of diagnosis.
Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.
Z. Tariq, Grazia Aleppo, Anders L. Carlson et al.· Endocrine Practice· 0 citations
Continuation of insulin pumps was associated with improvement in hyperglycemia without increased hypoglycemia risk and with shorter LOS in the hospital and standardized institutional policies may help expand safe continuation of AID during hospitalizations.
Kathleen R Ruddiman, J. Evans, Joseph A. Aloi et al.· Journal of Diabetes Science...· 0 citations
CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.
M. Marigliano, A. Scaramuzza, C. Arnaldi et al.· Diabetes Technology & Therap...· 0 citations
CGM-informed basal insulin optimization with a prototype of Dexcom Smart Basal was associated with improvements in glycemic control and treatment satisfaction in adults with T2D, with a favorable safety profile, and the system may help overcome clinical inertia and support individualized insulin titration in real-world...
S. Oser, C. Crystal, K. Hames et al.· Diabetes Therapy· 0 citations
A simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion, which modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG.
I. Aganj, N. Bryant, Leah Morgan Panaro et al.· medRxiv· 0 citations
The most common CGM devices are presented, along with a cost-effectiveness analysis and a critical assessment, and future perspectives are discussed, including AI technologies and modern solutions to enhance user comfort.
Oskar Kublin, D. Filipowicz, Mariusz Stępień· Archives of Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.